CVE-2026-79608x86/AMD: ineffectual Zenbleed workaround
Updated under an hour ago ()
Does this affect you?
It affects Xen. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.35%, higher than 28% of scored CVEs.
Do this next
Free account, 1 product
The workaround for XSA-433 (Zenbleed, CVE-2023-20593) was later re-worked to better integrate with other manipulations of the same MSR. In this rework an inverted conditional was introduced, resulting in the workaround to not be applied when needed and vice versa. For more details, see: http://xenbits.xen.org/xsa/advisory-433.html
- CVSS
- 9.8 CRITICAL (v3.1, CISA ADP)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-670
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.35% (percentile 28)
- Assigned by
- XEN
- NVD analysis
- Awaiting Analysis
- Record last updated
- Oct 20, 2026
- First seen by InfoSec Signals
- Oct 13, 2026
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.